Vestmark Advisory Solutions Inc. Invests $6.89 Million in Teladoc Health, Inc. (NYSE:TDOC)

Vestmark Advisory Solutions Inc. acquired a new stake in Teladoc Health, Inc. (NYSE:TDOC - Free Report) in the 4th quarter, according to its most recent disclosure with the SEC. The fund acquired 319,785 shares of the health services provider's stock, valued at approximately $6,891,000. Vestmark Advisory Solutions Inc. owned approximately 0.19% of Teladoc Health at the end of the most recent reporting period.

Several other hedge funds have also recently bought and sold shares of the company. ARK Investment Management LLC grew its stake in shares of Teladoc Health by 4.5% during the fourth quarter. ARK Investment Management LLC now owns 21,224,565 shares of the health services provider's stock worth $457,389,000 after buying an additional 912,692 shares during the last quarter. Charles Schwab Investment Management Inc. grew its position in Teladoc Health by 37.0% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 1,549,585 shares of the health services provider's stock worth $28,807,000 after acquiring an additional 418,909 shares during the last quarter. Robeco Institutional Asset Management B.V. grew its position in Teladoc Health by 49.4% during the 3rd quarter. Robeco Institutional Asset Management B.V. now owns 453,861 shares of the health services provider's stock worth $8,437,000 after acquiring an additional 149,976 shares during the last quarter. International Assets Investment Management LLC increased its holdings in Teladoc Health by 1,777.0% in the 4th quarter. International Assets Investment Management LLC now owns 112,038 shares of the health services provider's stock worth $2,414,000 after purchasing an additional 106,069 shares in the last quarter. Finally, Lecap Asset Management Ltd. bought a new stake in shares of Teladoc Health during the fourth quarter worth about $1,530,000. 76.82% of the stock is owned by institutional investors.

Analysts Set New Price Targets

A number of brokerages have recently commented on TDOC. DA Davidson cut their price target on shares of Teladoc Health from $22.00 to $18.00 and set a "neutral" rating on the stock in a report on Wednesday, February 21st. Needham & Company LLC reaffirmed a "hold" rating on shares of Teladoc Health in a report on Friday, April 26th. Stifel Nicolaus decreased their price target on Teladoc Health from $21.00 to $16.00 and set a "hold" rating for the company in a research note on Friday, April 26th. Citigroup cut their price objective on Teladoc Health from $21.00 to $19.00 and set a "neutral" rating on the stock in a research note on Wednesday, February 21st. Finally, Canaccord Genuity Group decreased their target price on shares of Teladoc Health from $28.00 to $25.00 and set a "buy" rating for the company in a research report on Friday, April 26th. Twelve research analysts have rated the stock with a hold rating and six have given a buy rating to the company. According to MarketBeat.com, the company presently has an average rating of "Hold" and a consensus price target of $18.73.

Insider Buying and Selling

In related news, CEO Jason N. Gorevic sold 53,755 shares of the company's stock in a transaction that occurred on Monday, March 4th. The shares were sold at an average price of $14.52, for a total transaction of $780,522.60. Following the sale, the chief executive officer now directly owns 653,073 shares in the company, valued at approximately $9,482,619.96. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. In related news, CEO Jason N. Gorevic sold 53,755 shares of the stock in a transaction dated Monday, March 4th. The stock was sold at an average price of $14.52, for a total transaction of $780,522.60. Following the sale, the chief executive officer now owns 653,073 shares of the company's stock, valued at approximately $9,482,619.96. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Laizer Kornwasser sold 10,411 shares of the firm's stock in a transaction that occurred on Thursday, May 2nd. The shares were sold at an average price of $12.69, for a total transaction of $132,115.59. Following the completion of the transaction, the insider now owns 86,070 shares of the company's stock, valued at $1,092,228.30. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 138,368 shares of company stock worth $1,989,227. Insiders own 0.95% of the company's stock.

Teladoc Health Stock Down 1.6 %

TDOC traded down $0.21 during midday trading on Friday, hitting $12.78. The company had a trading volume of 6,206,900 shares, compared to its average volume of 5,358,721. The stock's 50 day moving average price is $14.40 and its 200 day moving average price is $17.51. Teladoc Health, Inc. has a 52 week low of $12.53 and a 52 week high of $30.41. The company has a market capitalization of $2.17 billion, a price-to-earnings ratio of -9.06 and a beta of 0.97. The company has a quick ratio of 3.47, a current ratio of 3.82 and a debt-to-equity ratio of 0.67.

Teladoc Health (NYSE:TDOC - Get Free Report) last posted its quarterly earnings results on Thursday, April 25th. The health services provider reported ($0.49) earnings per share for the quarter, missing analysts' consensus estimates of ($0.47) by ($0.02). Teladoc Health had a negative return on equity of 10.13% and a negative net margin of 8.90%. The firm had revenue of $646.13 million for the quarter, compared to analyst estimates of $637.31 million. During the same period last year, the company posted ($0.37) earnings per share. The firm's quarterly revenue was up 2.7% compared to the same quarter last year. On average, research analysts anticipate that Teladoc Health, Inc. will post -1.04 earnings per share for the current fiscal year.

Teladoc Health Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.